INDIA
Zydus Cadila Gets DCGI Nod for Emergency Use of ‘Virafin’ in Treating Moderate COVID-19 Cases
The Drugs Controller General of India (DCGI) on Friday approved the emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate COVID-19 infection in adults.
The Drugs Controller General of India (DCGI) on Friday approved the emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate COVID-19 infection in adults.
Drugs Controller General of India (DGCI) approves emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate #COVID19 infection in adults. pic.twitter.com/bXBvHZaIBp
— ANI (@ANI) April 23, 2021
(The above story first appeared on LatestLY on Apr 23, 2021 03:58 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
